Efficacy of amikacin combinations for nocardiosis

Keiji Kanemitsu, Hiroyuki Kunishima, Tomoo Saga, Hideo Harigae, Shiho Ishikawa, Hiromu Takemura, Mitsuo Kaku

研究成果: Article査読

17 被引用数 (Scopus)


We isolated five bacterial strains from patients diagnosed as having nocardiosis. Bacterial species were identified based on the similarities in the nucleotide sequences of 16S ribosomal RNAs. Three of the five strains were identified as Nocardia asteroids, but unexpectedly other two were Streptomyces hygroscopicus and Rothia dentocariosa. The latter two species are not members of the family Nocardiaceae. We investigated the susceptibilities of these five strains to the following nine antimicrobial agents: trimethoprim/sulfamethoxazole (TMP/SMX), minocycline (MINO), erythromycin (EM), amikacin (AMK), cefotaxime (CTX), faropenem (FRPM), imipenem (IPM), ciprofloxacin (CPFX), and sparfloxacin (SPFX). The minimum inhibitory concentration (MIC) ranges (mg/ml) were as follows: TMP-SMX, 4->32; MINO, 0.125-8; EM, &IE;0.016->32; AMK, 1-2; CTX, 0.063->32; FRPM, 0.063-16; IPM, 0.125-2; CPFX, 4-32; and SPFX, 0.5-16. Moreover, the synergistic effects of AMK in combination with each of TMP-SMX, MINO, EM, CTX, IPM, and SPFX were investigated by checkerboard synergy testing. No antagonism was recognized for the three N. asteroides strains. Synergistic and additive effects were observed for the combinations of AMK with CTX, IPM, or SPFX.

ジャーナルTohoku Journal of Experimental Medicine
出版ステータスPublished - 2003 11月

ASJC Scopus subject areas

  • 生化学、遺伝学、分子生物学(全般)


「Efficacy of amikacin combinations for nocardiosis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。